Medicilon
Business Services · United Kingdom · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
Ely Rd, Cambridge, Cambridgeshire, CB24 ...Phone Number
+44 7723607137Website
www.medicilon.comRevenue
$162.4 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
2
1
1
About Medicilon
Since the founding of the company's company in 2004, Medicilon (Stock Code: 688202.SH) has grown into one of the professional drug discovery contract research organizations (CRO) in China. Over the years, Medicilon keeps improving their services in biotechnology and pharmaceutical research. Their services now span across medicinal chemistry, process chemistry, in vitro and in vivo DMPK, preclinical development and bioanalytical support. Medicilon grows together with the clients and delivers the new drug research and development services to more than 900 clients globally. Medicilon is proud to contribute to human health in the globe.Explore more
Medicilon Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Medicilon your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Medicilon launches new products
Earning: See what the market has to say on Medicilon recently announced quarterly report
Check if Medicilon has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Medicilon
Check out if Medicilon is spiking on competitors!
Website visits: Recent activity has been detected on your website
Medicilon, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Medicilon had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Medicilon has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Medicilon as Masked Content
Find more new buyers
Compare Similar Companies to Medicilon
Compare insights from companies similar to Medicilon, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Medicilon is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Medicilon is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Medicilon.
Medicilon Tech Stack
A closer look at the technologies used by Medicilon
Most Recent Scoops
Hiring Plans
Medicilon is hiring in Marketing for the first time in 12 months.
Hiring Plans
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Event
Events, Engineering, Research & Development, Training, Machine Learning, Learning & Development, Search, Laboratory Operations, Medical Education & Training, Medical Research, Chemical Engineering, Artificial Intelligence, Clinical Operations, Healthcare Technology, HR Operations, Operations
Event
Product Marketing, Events, Engineering, Sales, Bioengineering, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Operations
New Hire
Executive Move
Executive Moves, New Hire
Medicilon News & Media
Oncotelic Accesses Rapid IND Development Platform through Partnership with Medicilon
AGOURA HILLS, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB:OTLC). Oncotelic Therapeutics Inc., a leader in RNA-based therapeutics, including its subsidiaries (“Oncotelic”) and including Sapu Bioscience, LLC (“SAPU”), a wholly owned subsidiary of GMP Biotechnology Limited in which Oncotelic is a 45% owner, is pleased to announce a strategic partnership with Shanghai Medicilon Inc. (“Medicilon”) (stock code: 688202.SH). Through this collaboration, Oncotelic and SAPMedicilon Appoints Dr. Lilly Xu as Chief Technology Officer
BOSTON, Dec. 20, 2024 /PRNewswire/ -- Medicilon, a leading preclinical contract research organization (CRO), has named Dr. Lilly Xu as its new Chief Technology Officer (CTO). With over 30 years of experience in preclinical drug development, Dr. Xu will lead Medicilon's technological...Medicilon Appoints Dr. Lilly Xu as Chief Technology Officer
BOSTON, Dec. 20, 2024 /PRNewswire/ -- Medicilon, a leading preclinical contract research organization (CRO), has named Dr. Lilly Xu as its new Chief Technology Officer (CTO). With over 30 years of experience in preclinical drug development, Dr. Xu will lead Medicilon's technological...Medicilon Expands Global Presence with Official Opening of Second R&D Center in Massachusetts
BOSTON, Aug. 29, 2024 /PRNewswire/ -- In August 2024, Medicilon USA Corp (Medicilon) officially commenced operations at its second R&D center in Massachusetts, USA. Research at the new facility will focus on animal models for PK/PD and toxicology studies. This milestone heralds...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Medicilon
Sign Up For FreeTo access detailed company insights
Since the founding of the company's company in 2004, Medicilon (Stock Code: 688202.SH) has grown into one of the professional drug discovery contract research organizations (CRO) in China. Over the years, Medicilon keeps improving their services in biotechnology and pharmaceutical research. Their services now span across medicinal chemistry, proces... Read More
